TriSalus Life Sciences, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $45.2 | $29.4 | $18.5 | $12.4 | — |
| Operating income | -$26.9 | -$36.2 | -$54.5 | -$36.4 | -$3.0 |
| Net income | -$39.2 | -$30.0 | -$59.4 | -$47.2 | $4.8 |
| Cash Flow Statement | |||||
| Free cash flow | -$18.9 | -$41.2 | -$51.2 | -$33.0 | — |
| Share repurchases | — | — | — | $232.4 | — |
Shares outstanding 61.6M · Free float 45.9%
Annual filing data through FY ended December 31, 2025; float as of September 13, 2026.